7Baggers
Quarterly
Annual
    Unit: USD2020-09-30 2020-06-30 2019-03-31 2018-09-30 2018-06-30 
      
         
      assets
         
      current assets:
         
      cash
    79,551,041 23,586,442 60,809,779 47,515,790 9,232,069 
      prepaid expenses and other current assets
    1,095,331 750,023 302,945 240,883 227,709 
      total current assets
    80,646,372 24,336,465 61,123,210 47,838,599 9,533,668 
      property, plant and equipment
    7,388,376 7,976,411 7,525,450 8,230,945 8,503,667 
      operating lease right-of-use assets
    2,698,344 2,743,600 3,909,054   
      other assets
    378,043 378,043    
      total assets
    91,111,135 35,434,519 73,719,913 57,230,383 20,782,630 
      liabilities and stockholders’ equity
         
      current liabilities:
         
      accounts payable
    3,414,978 2,520,467 5,987,577 2,907,757 3,578,949 
      accrued compensation
    2,068,480 2,141,133 944,192 1,866,872 1,606,916 
      accrued stock offering expenses
     65,000    
      other accrued expenses
    1,409,976 1,068,276    
      current portion of operating lease liabilities
    638,862 614,083 477,008   
      current portion of finance lease liabilities
    1,113,670 1,336,833 899,512   
      current portion of long-term debt
    5,585,636 5,585,636 924,505 293,274 6,694,979 
      total current liabilities
    14,231,602 13,331,428 10,982,542 7,634,290 14,537,182 
      long-term operating lease liabilities
    5,183,539 5,350,198 6,102,448   
      long-term finance lease liabilities
    310,513 378,547 1,349,180   
      long-term debt
    6,104,374 7,504,757 9,896,576 10,726,433 5,720,910 
      total liabilities
    25,830,028 26,564,930 36,402,666 29,374,847 33,695,997 
      commitments and contingencies
         
      stockholders’ equity:
         
      preferred stock — 10,000,000 shares authorized as of september 30, 2020 and december 31, 2019, 0 shares issued and outstanding as of september 30, 2020 and december 31, 2019
         
      common stock — 0.001 par value, 60,000,000 and 40,000,000 shares authorized as of september 30, 2020 and december 31, 2019, respectively, 37,752,261 and 28,231,267 shares issued and outstanding as of september 30, 2020 and december 31, 2019, respectively
    37,752     
      additional paid-in capital
    324,159,065 252,788,245 218,721,394 185,208,219 134,647,022 
      accumulated deficit
    -258,915,710 -243,947,030 -181,422,784 -157,368,161 -147,695,149 
      total stockholders’ equity
    65,281,107 8,869,589 37,317,247 27,855,536  
      total liabilities and stockholders’ equity
    91,111,135 35,434,519 73,719,913 57,230,383  
      preferred stock — 10,000,000 shares authorized as of june 30, 2020 and december 31, 2019, 0 shares issued and outstanding as of june 30, 2020 and december 31, 2019
         
      common stock — 0.001 par value, 60,000,000 shares authorized as of june 30, 2020 and december 31, 2019, 28,374,585 and 28,231,267 shares issued and outstanding as of june 30, 2020 and december 31, 2019, respectively
     28,374    
      accounts receivable
      10,486   
      prepaid expenses and other assets
      1,162,199 1,160,839 2,745,295 
      accrued expenses
      1,749,748 1,439,602 1,428,932 
      deferred rent
       268,599 268,599 
      long-term deferred rent
       2,458,186 2,509,651 
      long-term deferred revenue
      8,071,920 8,071,921 8,071,921 
      preferred stock — series a, 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      preferred stock — series a-1, 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      preferred stock — series b, 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      preferred stock — series c, 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      preferred stock — series c-1, 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      preferred stock — series d, 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      common stock — class b (non-voting), 0.001 par value, 0 shares authorized, issued and outstanding as of march 31, 2019 and december 31, 2018
         
      common stock — 0.001 par value, 40,000,000 shares authorized as of march 31, 2019 and december 31, 2018, 18,637,012 and 15,519,469 issued and outstanding as of march 31, 2019 and december 31, 2018, respectively
      18,637   
      accounts receivables
       81,926 73,890 
      accrued interest
       59,505 27,241 
      current portion of capital lease obligations
       471,981 500,627 
      current portion of deferred revenue
       326,700 430,939 
      long-term capital lease obligations
       484,017 564,924 
      deferred financing obligation
         
      warrant liabilities
        2,291,409 
      stockholders’ equity
         
      preferred stock — series a, 0.001 par value, 0 and 1,974,430 shares authorized, issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      preferred stock — series a-1, 0.001 par value, 0 and 1,834,862 shares authorized, issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      preferred stock — series b, 0.001 par value, 0 and 4,620,123 shares authorized as of september 30, 2018 and december 31, 2017, respectively, 0 and 4,496,908 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      preferred stock — series c, 0.001 par value, 0 and 17,102,578 shares authorized, issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      preferred stock — series c-1, 0.001 par value, 0 and 91,000,000 shares authorized as of september 30, 2018 and december 31, 2017, respectively, 0 and 17,556,178 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      preferred stock — series d, 0.001 par value, 0 shares authorized, issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      common stock — class b (non-voting), 0.001 par value, 0 and 330,664 shares authorized as of september 30, 2018 and december 31, 2017, respectively, 0 and 19,645 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
         
      common stock — 0.001 par value, 40,000,000 and 175,000,000 shares authorized as of september 30, 2018 and december 31, 2017, respectively, 15,478,286 and 549,952 issued and outstanding as of september 30, 2018 and december 31, 2017, respectively
       15,478  
      liabilities and stockholders’ deficit
         
      stockholders’ deficit:
         
      preferred stock — series a, 0.001 par value, 1,974,430 shares authorized, issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017, liquidation preference of 2,625,992
        1,974 
      preferred stock — series a-1, 0.001 par value, 1,834,862 shares authorized, issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017, liquidation preference of 6,000,000
        1,835 
      preferred stock — series b, 0.001 par value, 4,620,123 shares authorized, 4,496,908 shares issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017, liquidation preference of 16,000,000
        4,497 
      preferred stock — series c, 0.001 par value, 17,102,578 shares authorized, issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017, liquidation preference of 25,000,035
        17,103 
      preferred stock — series c-1, 0.001 par value, 21,254,306 shares authorized as of june 30, 2018 (unaudited) and december 31, 2017, 17,556,178 shares issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017, liquidation preference of 14,000,000
        17,556 
      preferred stock — series d, 0.001 par value, 137,423,317 shares authorized, 91,147,482 issued and outstanding as of june 30, 2018 (unaudited), 0 shares authorized, issued and outstanding as of december 31, 2017, liquidation preference of 54,513,495
        91,147 
      common stock — class a (voting), 0.001 par value, 265,000,000 and 175,000,000 shares authorized as of june 30, 2018 (unaudited) and december 31, 2017, respectively, 628,130 and 549,952 issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017, respectively
        628 
      common stock — class b (non-voting), 0.001 par value, 330,664 shares authorized, 19,645 shares issued and outstanding as of june 30, 2018 (unaudited) and december 31, 2017
        20 
      total stockholders’ deficit
        -12,913,367 
      total liabilities and stockholders’ deficit
        20,782,630 
      revenues
        1,042,879 
      costs and expenses:
         
      cost of sales
        94,342 
      research and development
        5,917,702 
      general and administrative
        1,991,231 
      total costs and expenses
        8,003,275 
      income from operations
        -6,960,396 
      other income:
         
      interest income
        11,846 
      interest expense
        -245,711 
      derivative and warrant fair value adjustments
        925,337 
      total other income
        691,472 
      net income
        -6,268,924 
      other comprehensive loss
         
      comprehensive loss
        -6,268,924 
      per share data:
         
      basic and diluted net income per share
        -9.86 
      weighted-average common shares outstanding, basic and diluted
        636,063 
      pro forma basic and diluted net income per share
        -0.59 
      pro forma weighted-average basic and diluted shares outstanding
        10,584,270 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.